Orlistat reduces absorption of fat-soluble vitamins A, D, E, and K, raising nutritional concerns during the pre-conception period
Subjects in both studies received PAXLOVID (nirmatrelvir/ritonavir 300 mg/100 mg) or placebo every 12 hours for 5 days for the treatment of mild-to-moderate COVID-19 within 5 days of symptom onset [see Clinical Studies (14)]: Adverse reactions were those reported while subjects were on study medication and through 28 days after the last dose of study treatment
The primary concern relates to delayed gastric emptying , which could potentially increase the risk of pulmonary aspiration during anaesthesia
Findings: RCTSTEP 3 Trial - Wegovy vs Placebo for Weight Loss in Overweight Adults Without DM, JAMA (2021) [PubMed abstract] Design: Randomized, placebo-controlled trial (N=611 | length = 68 weeks) in overweight or obese adults (average weight 233 lbs | average BMI 38) without diabetes Treatment: Wegovy 2.4 mg sub-q once weekly vs Placebo
It explains both its ~14.9% peak weight loss in STEP 1 and its dose-limiting nausea profile, gastric-emptying delay is the same pathway that drives upper-GI side effects
Ozempic injection is a pre-filled pen injected under the skin (subcutaneously)
